You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory AML

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial (CD33KO-HSPC; CART33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • CD33KO-HSPC; CART33
  • (no location specified)
Jul 13, 2023

Myelodysplasia, Leukemia Trial in Providence (chemo)

Terminated
Has Results
  • Myelodysplasia
  • Leukemia
  • Providence, Rhode Island
    Lifespan Hospitals
Jan 5, 2022

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Atlanta, New York (MRX-2843)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Atlanta, Georgia
  • +2 more
Jul 6, 2022

Acute Myeloid Leukemia Trial (WU-NK-101)

Not yet recruiting
  • Acute Myeloid Leukemia
  • WU-NK-101
  • (no location specified)
Jul 20, 2022

Acute Myeloid Leukemia Trial in Hanzhou (Clifutinib Besylate)

Recruiting
  • Acute Myeloid Leukemia
  • Clifutinib Besylate
  • Hanzhou, China
    the First Affiliated Hospital,College of Medicine,Zhejiang Unive
Aug 10, 2022

Acute Myeloid Leukemia Trial (TCB008)

Recruiting
  • Acute Myeloid Leukemia
  • Bristol, United Kingdom
  • +5 more
Jan 10, 2023

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +2 more
May 19, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Seattle (SC-DARIC33)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • SC-DARIC33
  • Seattle, Washington
    Seattle Children's Hospital
Sep 6, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (BP1002; Liposomal Bcl-2 Antisense

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide
  • Decitabine (in combination with BP1002)
  • (no location specified)
Mar 8, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome
  • ASP7517
  • Duarte, California
  • +15 more
Jan 19, 2023

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
  • Hefei, Anhui, China
  • +7 more
Jun 27, 2023

NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

Recruiting
  • NHL, Adult
  • AML, Adult Recurrent
  • Zhengzhou, Henan, China
  • +1 more
Feb 24, 2023

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia Trial in Saint Louis (biological, drug, procedure)

Not yet recruiting
  • Refractory Acute Myeloid Leukemia
  • Relapsed Acute Myeloid Leukemia
  • Cytokine induced memory-like NK cells
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 30, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Boston, Massachusetts
  • +2 more
Jan 18, 2023

AML Trial in Hangzhou (ADGRE2 CAR-T)

Not yet recruiting
  • AML
  • ADGRE2 CAR-T
  • Hangzhou, China
    Mingming Zhang Zhang
Jul 17, 2022

Acute Myeloid Leukaemia Trial (SAR445419, fludarabine, cytarabine)

Not yet recruiting
  • Acute Myeloid Leukaemia
  • (no location specified)
Feb 2, 2023

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

AML Trial in Hangzhou (CLL1 CAR-T)

Not yet recruiting
  • AML
  • CLL1 CAR-T
  • Hangzhou, China
    The First Affiliated Hospital, Zhejiang University
Jul 17, 2022

MDS, Acute Myeloid Leukemia Trial in France (BST-236)

Recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Amiens, France
  • +16 more
Jan 2, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

Suspended
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022